H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Alphatec Holdings (NASDAQ: ATEC) today and set a price target of $4. The company’s shares closed yesterday at $3.69.
According to TipRanks.com, Ramakanth is a 3-star analyst with an average return of 4.1% and a 37.5% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Diffusion Pharmaceuticals Inc, IntelGenx Technologies, and Eleven Biotherapeutics.
Alphatec Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $4.
See today’s analyst top recommended stocks >>
Based on Alphatec Holdings’ latest earnings release for the quarter ending December 31, the company reported a quarterly net profit of $9.06 million. In comparison, last year the company had a GAAP net loss of $5.52 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alphatec Holdings, Inc. engages in the design, development, and promotion of products for the surgical treatment of spine disorders. The company products include spinal fixation, universal spacer, anterior cervical plate, and MIS posterior fixation system. It operates through the United States and International geographical segments.
